Zentalis Pharmaceuticals

Zentalis Pharmaceuticals ZNTL Stock

$1.36   -8.724830%
Add to favorites
Market Cap
$133.64M
LOW - HIGH [24H]
$1.36 - $1.52
VOLUME [24H]
$1.21M
P/E Ratio
0
Earnings per share
-$1.90
ISIN
US98943L1070
Price   Prediction

Zentalis Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Zentalis Pharmaceuticals (ZNTL) stock price today is 1.36 USD on Tech Market Middle (-8.72% on the day). Updated .

Zentalis Pharmaceuticals ZNTL Financial and Trading Overview

Zentalis Pharmaceuticals stock price 1.36 USD
Previous Close 1.49 USD
Open 1.5 USD
Bid 3.53 USD x 200
Ask 6.28 USD x 200
Day's Range 1.36 - 1.52 USD
52 Week Range 1.28 - 6.95 USD
Volume 1.21M USD
Avg. Volume 1.26M USD
Market Cap 133.64M USD
Beta (5Y Monthly) 1.929
PE Ratio (TTM) N/A
EPS (TTM) -1.9 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 7.44 USD

ZNTL Valuation Measures

Enterprise Value -58543428 USD
Trailing P/E N/A
Forward P/E -0.89213085
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.6522782
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.398

Trading Information

Zentalis Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.929
52-Week Change 12.03%
S&P500 52-Week Change 10.51%
52 Week High 6.95 USD
52 Week Low 1.28 USD
50-Day Moving Average 2.43 USD
200-Day Moving Average 3.39 USD

ZNTL Share Statistics

Avg. Volume (3 month) 1.26M USD
Avg. Daily Volume (10-Days) 1.49M USD
Shares Outstanding 98.27M
Float 78.41M
Short Ratio 3.74
% Held by Insiders 21.05%
% Held by Institutions 65.38%
Shares Short 5.04M
Short % of Float 6.00%
Short % of Shares Outstanding 5.12%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -30.92%
Return on Equity (ttm) -61.89%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -147196000 USD
Net Income Avi to Common (ttm) -141668992 USD
Diluted EPS (ttm) -1.9
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 228.89M USD
Total Cash Per Share (mrq) 2.33 USD
Total Debt (mrq) 36.71M USD
Total Debt/Equity (mrq) 17.92 USD
Current Ratio (mrq) 7.331
Book Value Per Share (mrq) 2.085

Cash Flow Statement

Operating Cash Flow (ttm) -133839000 USD
Levered Free Cash Flow (ttm) -85149624 USD

Profile of Zentalis Pharmaceuticals

Country United States
State CA
City San Diego
Address 10275 Science Center Dr.
ZIP 92121
Phone 858 263 4333
Website https://zentalis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 106

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.

Q&A For Zentalis Pharmaceuticals Stock

What is a current ZNTL stock price?

Zentalis Pharmaceuticals ZNTL stock price today per share is 1.36 USD.

How to purchase Zentalis Pharmaceuticals stock?

You can buy ZNTL shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Zentalis Pharmaceuticals?

The stock symbol or ticker of Zentalis Pharmaceuticals is ZNTL.

Which industry does the Zentalis Pharmaceuticals company belong to?

The Zentalis Pharmaceuticals industry is Biotechnology.

How many shares does Zentalis Pharmaceuticals have in circulation?

The max supply of Zentalis Pharmaceuticals shares is 98.27M.

What is Zentalis Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Zentalis Pharmaceuticals PE Ratio is now.

What was Zentalis Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Zentalis Pharmaceuticals EPS is -1.9 USD over the trailing 12 months.

Which sector does the Zentalis Pharmaceuticals company belong to?

The Zentalis Pharmaceuticals sector is Healthcare.

Zentalis Pharmaceuticals ZNTL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.16B USD — 24225.3 USD — 24538.78 USD — — 7.16B USD —
us US Tech Global Market Composite NQGM US 1839.01 USD —
+0.18
— — 1830.2 USD — 1855.92 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 2940.71 USD —
+0.45
— — 2921.79 USD — 2965.84 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$72.73B
Total volume
BTC 58.90%   •   ETH 10.13%
Dominance
Select currency